Gylling A, Abdel-Rahman W M, Juhola M, Nuorva K, Hautala E, Järvinen H J, Mecklin J-P, Aarnio M, Peltomäki P
Department of Medical Genetics, University of Helsinki, Biomedicum Helsinki, P O Box 63 (Haartmaninkatu 8), Helsinki 00014 Finland.
Gut. 2007 Jul;56(7):926-33. doi: 10.1136/gut.2006.114876. Epub 2007 Jan 31.
Gastric cancer is the second most common extracolonic malignancy in individuals with hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome. As gastric cancer is relatively common in the general population as well, it is not clear whether or not gastric cancer is a true HNPCC spectrum malignancy.
To determine whether or not gastric cancer is a true HNPCC spectrum malignancy.
The molecular and clinicopathological profiles of gastric cancers (n = 13) from HNPCC mutation carriers were evaluated and compared with the profiles of sporadic gastric cancers (n = 46) stratified by histology and microsatellite instability (MSI) status.
This study on sporadic and HNPCC gastric cancers revealed several important universal associations. Loss of heterozygosity in the adenomatous polyposis coli (APC) region was associated with intestinal histology regardless of the MSI (p = 0.007). KRAS-mutations (p = 0.019) and frameshift mutations in repeat tracts of growth-regulatory genes (p<0.001) were associated with MSI tumours being absent in microsatellite stable (MSS) tumours. The average number of methylated tumour suppressor gene loci among the 24 genes studied (methylation index) was higher in MSI than in MSS tumours regardless of histology (p<0.001). Gastric cancers from HNPCC mutation carriers resembled sporadic intestinal MSI gastric cancers, except that MLH1 promoter methylation was absent (p<0.001) and the general methylation index was lower (p = 0.038), suggesting similar, but not identical, developmental pathways. All these lacked the mismatch repair protein corresponding to the germline mutation and displayed high MSI.
The present molecular evidence, combined with the previous demonstration of an increased incidence relative to the general population, justify considering gastric cancers as true HNPCC spectrum malignancies.
在遗传性非息肉病性结直肠癌(HNPCC)/林奇综合征患者中,胃癌是第二常见的结肠外恶性肿瘤。由于胃癌在普通人群中也相对常见,因此尚不清楚胃癌是否为真正的HNPCC谱系恶性肿瘤。
确定胃癌是否为真正的HNPCC谱系恶性肿瘤。
对HNPCC突变携带者的13例胃癌的分子和临床病理特征进行评估,并与按组织学和微卫星不稳定性(MSI)状态分层的46例散发性胃癌的特征进行比较。
这项关于散发性和HNPCC胃癌的研究揭示了几个重要的普遍关联。无论MSI如何,腺瘤性息肉病 coli(APC)区域的杂合性缺失与肠组织学相关(p = 0.007)。KRAS突变(p = 0.019)和生长调节基因重复序列中的移码突变(p<0.001)与微卫星稳定(MSS)肿瘤中不存在MSI肿瘤相关。无论组织学如何,在研究的24个基因中,MSI肿瘤中甲基化肿瘤抑制基因位点的平均数量(甲基化指数)高于MSS肿瘤(p<0.001)。HNPCC突变携带者的胃癌类似于散发性肠MSI胃癌,不同之处在于MLH1启动子甲基化不存在(p<0.001)且总体甲基化指数较低(p = 0.038),这表明发育途径相似但不完全相同。所有这些都缺乏与种系突变相对应的错配修复蛋白,并表现出高MSI。
目前的分子证据,结合先前相对于普通人群发病率增加的证明,证明将胃癌视为真正的HNPCC谱系恶性肿瘤是合理的。